Late Prednisone Withdrawal in Cyclosporine-Treated Kidney Transplant Patients: A Randomized Study

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 294-301

  Hollander, Adrianus A M J ^a,e   Hene, Ronald J ^b   Hermans, Jo ^c   Van Es, Leendert ^a   Van Der Woude, Fokko J ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME;

ADULT; AGED; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; TIME FACTORS;

EID: 0031065640     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Murray JE, Merrill JP, Harrison JH, Wilson RE, Damin GJ: Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 268: 1315-1323, 1963
2. Starzl TE, Klintermalm GBG, Weil R, Porter KA, Jwatsuki S, Schroter GPJ, Fernandez C, MacHugh H: Cyclosporin-A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet 153: 486-494, 1981
3. European Multicentre Trial Group: Cyclosporin in cadaveric renal transplantation: One-year follow-up of a multicentre trial. Lancet II: 986-989, 1983
4. Opelz G: Collaborative transplant study: 10 year report. Transplant Proc 24: 2342-2355, 1992
5. Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G: Comparison of three immunosuppressive regimens in cadaver renal transplantation: Long term cyclosporine, short term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 318: 1499-1507, 1988
6. Hollander AAMJ, van Saase JLCM, Kootte AMM, van Dorp WT, van Bockel HJ, van Es LA, van der Woude FJ: Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 345: 610-614, 1995
7. Calne RY, White DJG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GH, Pentlow BD, Rolles K: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet II:1323-1327, 1978
8. Griffin PJA, Gomes Da Costa CA, Salaman JR: A controlled trial of steroids in cyclosporine-treated renal transplant patients. Transplantation 43: 505-508, 1987
9. Johnson RWG, Mallick NP, Bakran A, Pearson RC, Scott PD, Dyer P, Donaghue D, Morris D, Gokal R: Cadaver renal transplantation without maintenance steroids. Transplant Proc 21: 1581-1582, 1989
10. Opelz G: Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 58: 443-446, 1994
11. Kjellstrand CM: Side effects of steroids and their treatment. Transplant Proc 7: 123-129, 1975
12. Popovtzer MM, Pinnggera W, Katz FH, Corman JL, Robinette J, Lanois B, Halgrimsen C, Starzl TE: Variations in arterial blood pressure after kidney transplantation; relation to renal function, plasma renin activity, and the dose of prednisone. Circulation 47: 1297-1305, 1973
13. Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC: Changes in causes of death after renal transplantation, 1966 to 1987. Am J Kidney Dis 17: 512-518, 1991
14. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD: Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325: 544-550, 1991
15. Davis GF: Adverse effects of corticosteroids. Clin Dermatol 4: 161-169, 1986
16. Schulak JA, Mayes JT, Moritz CE, Hricik DE: A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine treated renal transplant patients. Transplantation 49: 327-332, 1990
17. Maiorca R, Cristinelli L, Brunori G, Setti G, Salerni B, de Nobili U, Mittempergher F: Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Transplant Proc 20: 121-125, 1988.
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
19. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplantation. Kidney Int 44: 411-422, 1993
20. Hricik DE, Whalen CC, Lautman J, Bertucci MR, Moir EJ, Mayes JT, Schulak JA: Withdrawal of steroids after renal transplantation-clinical predictors of outcome. Transplantation 53: 41-45, 1992
21. Stratta RJ, Armbrust MJ, Oh CS, Pirsch JD, Kalayoblu M, Sollinger HW, Belzer FD: Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 45: 323-328, 1988
22. Kupin W, Venkat KK, Oh HK, Dienst S: Complete replacement of methyl-prednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 45: 53-55, 1988
23. Sinclair NRS, for the Canadian Multicentre Transplant Study Group: Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 147: 645-657, 1992
24. Cristinelli L, Setti G, Sandrini S, Scolari F, Scaini P, Maiorca R: Controlled randomized trial of steroid withdrawal after six months in renal transplant recipients treated with cyclosporine: Results at 4 years [Abstract]. Kidney Int 41: 1440, 1992
25. Griffin PJA, Salaman JR: Long-term results of cyclosporine monotherapy in kidney transplantation. Transplant Proc 23: 992-993, 1991
26. Yilmaz S, Hayry P: The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 56: 1153-1156, 1993
27. Almond PS, Matas A, Gillingham A, Dunn DL, Payne WD, Goves P, Gruessner R, Najarian JJ: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993
28. van Saase JLCM, van der Woude FJ, Thorogood J, Hollander AAMJ, van Es LA, Weening JJ, van Bockel JH, Bruyn JA: The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 59: 1280-1285, 1995
29. Johnson RWG, Mallick NP, Scott PD, Riad H, Pearson RC, Dyer P, Morris D, Gokal R: Prospective trials with cyclosporine monotherapy in cadaver renal transplantation. J Nephrol 4: 47-49, 1990
30. Hricik DE, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA: Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 53: 1232-1235, 1992
31. Waltzer WC, Turner S, Frohnert P, Rapaport FT: Etiology and pathogenesis of hypertension following renal transplantation. Nephron 42: 102-109, 1986
32. Bennett WM, Porter GA: Cyclosporine-associated hypertension. Am J Med 85: 131-133, 1988
33. LaRosa JC, Hunninghake D, Bush D, Criqui MH, Getz GS, Gotto AM: The cholesterol facts: A summery of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 81: 1721-1733, 1990
34. Markell MS, Brown CD, Butt KMH, Friedman EA: Prospective evaluation of changes in lipid profiles in cyclosporine-treated renal transplant patients. Transplant Proc 21: 1497-1499, 1989
35. Hricik DE, Mayes JT, Schulak JA: Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Am J Kidney Dis 18: 353-358, 1991
36. Kasiske BL, Umen AJ: Persistent hyperlipidemia in renal transplant patients. Medicine 66: 309-316, 1987
37. Kasiske BL, Tortorice KL, Heim-Duthoy KL, Awni WM, Rao KV: The adverse impact of cyclosporine on serum lipids in renal transplant recipients. Am J Kidney Dis 17: 700-707, 1991
38. Ettinger WH, Klinefelter HF, Kwiterovitch PO: Effect of short-term, low dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 63: 167-172, 1987
39. Ettinger WH, Hazzard WR: Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37: 1055-1058, 1988
40. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J: Posttransplant hyperglycemia. Transplantation 47: 278-281, 1989
41. Yagisawa T, Takahashi K, Teraoke S, Toma H, Agishi T, Ota K: Deterioration in glucose metabolism in cyclosporine-treated kidney transplant recipients and rats. Transplant Proc 18:1548-1551, 1986
42. Robertson RP: Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 35: 1016-1019, 1986
43. Ost L, Tyden G, Fehrman I: Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients. Transplantation 46: 370-372, 1988
44. Friedman EA, Shyh T, Beyer MM, Manis T, Butt KMH: Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 5: 196-202, 1985